- Telehealth Visits
- Insurance plan information
Dennis Shusterman, MD, MPH
Occupational-Environmental Medicine • Family Medicine- Telehealth Visits
- Insurance plan information
Dennis Shusterman, MD, MPH
Occupational-Environmental Medicine • Family Medicine- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Occupational Medicine, American Board of Preventitive Medicine
- Family Medicine, American Board of Family Medicine
Fellowship
- UCSF Medical Center GME/RESEARCH
Residency
- Family Practice, San Jose Medical Center - CLOSED
Internship
- Rotating, Waltham Hospital - CLOSED 2003
Degree
- MD, University of California Davis Medical Center
My expertise
Specialties
- Occupational-Environmental Medicine
- Family Medicine
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%22124%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22124%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.